4//SEC Filing
Menzaghi Frederique Ph.D. 4
Accession 0001209191-20-065581
CIK 0001346830other
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 6:15 PM ET
Size
5.4 KB
Accession
0001209191-20-065581
Insider Transaction Report
Form 4
Menzaghi Frederique Ph.D.
VP-Research & Development
Transactions
- Sale
Common Stock
2020-12-30$15.30/sh−2,812$43,024→ 109,680 total
Footnotes (2)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of the RSUs reported on Form 4 filed with the Securities and Exchange Commission on December 29, 2020, and does not represent a discretionary trade by the Reporting Person.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding as described in footnote (1).
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001597152
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 6:15 PM ET
- Size
- 5.4 KB